Article thumbnail

Association Between Plaque Thickness of the Thoracic Aorta and Recurrence of Atrial Fibrillation After Ablation

By Hui-Jeong Hwang, Man-Young Lee, Ho-Joong Youn, Yong-Seog Oh, Tae-Ho Rho, Wook-Sung Chung, Chul-Soo Park, Yun-Seok Choi, Woo-Baek Chung, Jae-Beom Lee, Hyun-Keun Park, KeunJoon Lim and Jae Hak Lee
Topics: Original Article
Publisher: The Korean Society of Cardiology
OAI identifier: oai:pubmedcentral.nih.gov:3098409
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1996). 20) Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography in atrial fibrillation: standards for acquisition and interpretation and assessment of interobserver variability.
  2. (1995). age distribution, and gender of patients with atrial fibrillation: analysis and implications.
  3. (1999). Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications.
  4. (2001). Association of atrial fibrillation and aortic atherosclerosis: a population-based study. Mayo Clin Proc
  5. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke.
  6. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
  7. Calcifications, arterial stiffness and atherosclerosis.
  8. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation.
  9. clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
  10. Correlation of left atrial diameter by echocardiography and left atrial volume by computed tomography.
  11. Detection and quantification of left arterial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.
  12. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on patients following ablation of atrial fibrillation.
  13. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes.
  14. Gene expression and ultrastructural remodeling in persistent atrial fibrillation.
  15. (2006). guide-Hui-Jeong Hwang, et al. 183 lines for the management of patients with atrial fibrillation.
  16. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation
  17. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study.
  18. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.
  19. (2006). Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol
  20. Long-term single procedure efficacy of catheter ablation of atrial fibrillation.
  21. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.
  22. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation.
  23. Prevalence of atrial fibrillation in middle-aged people in Korea: the Korean genome and epidemiology study.
  24. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.
  25. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
  26. Subclinical atherosclerosis and risk of atrial fibrillation.
  27. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.
  28. Venice chart international consensus document on atrial fibrillation ablation.
  29. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.